Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of ...

The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and, if ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs, for the second annual round of drug price ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...